Laurus Labs (BOM:540222) 3-Year Book Growth Rate : 16.40% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs 3-Year Book Growth Rate?

Laurus Labs's Book Value per Share for the quarter that ended in Mar. 2024 was ₹76.25.

During the past 12 months, Laurus Labs's average Book Value per Share Growth Rate was 1.70% per year. During the past 3 years, the average Book Value per Share Growth Rate was 16.40% per year. During the past 5 years, the average Book Value per Share Growth Rate was 23.90% per year. During the past 10 years, the average Book Value per Share Growth Rate was 22.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 11 years, the highest 3-Year average Book Value per Share Growth Rate of Laurus Labs was 41.80% per year. The lowest was 9.60% per year. And the median was 19.95% per year.

Competitive Comparison of Laurus Labs's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Laurus Labs's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laurus Labs's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laurus Labs's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Laurus Labs's 3-Year Book Growth Rate falls into.

Laurus Labs 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Laurus Labs (BOM:540222) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Laurus Labs 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Laurus Labs's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Laurus Labs (BOM:540222) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

LAURUSLABS:India

Address

Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034

Website

https://www.lauruslabs.com

Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs (BOM:540222) Headlines

No Headlines